Search research articles
Contact Us
Filters
Showing results (581-590 of 594) with videos related to
Page
of 60
Sort By:
Digestive Diseases and Sciences
|
August 24, 2018
Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a: Week 120 Analysis
Sang Hoon Ahn, Patrick Marcellin, Xiaoli Ma, et al.
Imetaomics
|
February 12, 2026
Transfer learning identifies bacterial signatures for cross-regional diagnosis of type 2 diabetes and enable stage-sensitive dietary fiber intervention
Qunye Zhang, Nan Wang, Fanghua Zhang, et al.
The Lancet. Gastroenterology & Hepatology
|
February 24, 2020
Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patients with chronic hepatitis B: a randomised, double-blind, phase 3, multicentre non-inferiority study
Pietro Lampertico, Maria Buti, Scott Fung, et al.
The American Journal of Gastroenterology
|
August 10, 2023
Long-Term Treatment With Tenofovir Alafenamide for Chronic Hepatitis B Results in High Rates of Viral Suppression and Favorable Renal and Bone Safety
Henry L Y Chan, Maria Buti, Young-Suk Lim, et al.
Neuro-Oncology Advances
|
October 25, 2021
Treatment barriers and clinical outcome of children with medulloblastoma in China: a report from the Chinese Children's Cancer Group (CCCG)
Anthony Pak-Yin Liu, Zijun Zhen, Qunying Yang, et al.
Nano Letters
|
March 16, 2022
Engineering Interlayer Electron-Phonon Coupling in WS<sub>2</sub>/BN Heterostructures
Yifei Li, Xiaowei Zhang, Jinhuan Wang, et al.
Gastroenterology
|
October 11, 2015
Combination of Tenofovir Disoproxil Fumarate and Peginterferon α-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B
Patrick Marcellin, Sang Hoon Ahn, Xiaoli Ma, et al.
Gastroenterology
|
April 2, 2019
Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis
Carolina Boni, Harry L A Janssen, Marzia Rossi, et al.
JHEP Reports : Innovation in Hepatology
|
March 21, 2024
Long-term open-label vebicorvir for chronic HBV infection: Safety and off-treatment responses
Man-Fung Yuen, Scott Fung, Xiaoli Ma, et al.
Journal of Hepatology
|
June 13, 2022
Safety and efficacy of vebicorvir administered with entecavir in treatment-naïve patients with chronic hepatitis B virus infection
Mark S Sulkowski, Kosh Agarwal, Xiaoli Ma, et al.
Page
of 60
Search research articles
Search
Showing results (581-590 of 594) with videos related to
Sort By:
Page
of 60
Digestive Diseases and Sciences
|
August 24, 2018
Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a: Week 120 Analysis
Sang Hoon Ahn, Patrick Marcellin, Xiaoli Ma, et al.
Imetaomics
|
February 12, 2026
Transfer learning identifies bacterial signatures for cross-regional diagnosis of type 2 diabetes and enable stage-sensitive dietary fiber intervention
Qunye Zhang, Nan Wang, Fanghua Zhang, et al.
The Lancet. Gastroenterology & Hepatology
|
February 24, 2020
Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patients with chronic hepatitis B: a randomised, double-blind, phase 3, multicentre non-inferiority study
Pietro Lampertico, Maria Buti, Scott Fung, et al.
The American Journal of Gastroenterology
|
August 10, 2023
Long-Term Treatment With Tenofovir Alafenamide for Chronic Hepatitis B Results in High Rates of Viral Suppression and Favorable Renal and Bone Safety
Henry L Y Chan, Maria Buti, Young-Suk Lim, et al.
Neuro-Oncology Advances
|
October 25, 2021
Treatment barriers and clinical outcome of children with medulloblastoma in China: a report from the Chinese Children's Cancer Group (CCCG)
Anthony Pak-Yin Liu, Zijun Zhen, Qunying Yang, et al.
Nano Letters
|
March 16, 2022
Engineering Interlayer Electron-Phonon Coupling in WS<sub>2</sub>/BN Heterostructures
Yifei Li, Xiaowei Zhang, Jinhuan Wang, et al.
Gastroenterology
|
October 11, 2015
Combination of Tenofovir Disoproxil Fumarate and Peginterferon α-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B
Patrick Marcellin, Sang Hoon Ahn, Xiaoli Ma, et al.
Gastroenterology
|
April 2, 2019
Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis
Carolina Boni, Harry L A Janssen, Marzia Rossi, et al.
JHEP Reports : Innovation in Hepatology
|
March 21, 2024
Long-term open-label vebicorvir for chronic HBV infection: Safety and off-treatment responses
Man-Fung Yuen, Scott Fung, Xiaoli Ma, et al.
Journal of Hepatology
|
June 13, 2022
Safety and efficacy of vebicorvir administered with entecavir in treatment-naïve patients with chronic hepatitis B virus infection
Mark S Sulkowski, Kosh Agarwal, Xiaoli Ma, et al.
Page
of 60